Brunswick (NYSE: BC) director receives 697 deferred shares in grant

Rhea-AI Filing Summary

Brunswick Corporation director David C. Everitt reported an acquisition of 697 shares of Brunswick common stock on January 30, 2026, at $80.22 per share. The shares were credited as deferred stock into his director deferred account and will be paid out in set installments after he leaves the board.

Following this transaction, Everitt directly beneficially owned 38,020 Brunswick shares, which include 215 shares acquired through dividend reinvestments in December 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EVERITT DAVID C

(Last) (First) (Middle)

C/O BRUNSWICK CORPORATION

26125 N. RIVERWOODS BLVD. SUITE 500

(Street)

METTAWA IL 60045

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		697(1)	A	$80.22	38,020(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 215 shares acquired pursuant to dividend reinvestments in December 2025.

Remarks:

	By: Power of Attorney For: /s/ David C. Everitt	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Brunswick (BC) director David C. Everitt report?

Director David C. Everitt reported receiving 697 shares of Brunswick common stock. The shares were credited on January 30, 2026, at $80.22 per share as deferred stock in his director account, increasing his directly beneficially owned holdings.

At what price were the newly acquired Brunswick (BC) shares recorded?

The newly acquired 697 Brunswick common shares were recorded at $80.22 per share. This price applies to the deferred shares deposited into David C. Everitt’s director deferred account under the company’s director compensation and deferral arrangements.

How many Brunswick (BC) shares does David C. Everitt own after this Form 4 transaction?

After this transaction, David C. Everitt beneficially owns 38,020 Brunswick shares directly. This total includes the newly credited deferred shares as well as 215 shares that were added earlier through dividend reinvestments completed in December 2025.

What are deferred shares in the context of this Brunswick (BC) Form 4?

The deferred shares are deposited into the director’s deferred account instead of being paid immediately. For David C. Everitt, these deferred Brunswick shares will be automatically distributed in predetermined installments after he stops serving as a director of the company.

How do dividend reinvestments affect David C. Everitt’s Brunswick (BC) holdings?

David C. Everitt’s beneficial holdings include 215 Brunswick shares gained through dividend reinvestments. These shares were acquired in December 2025, adding to his overall directly beneficially owned position alongside the newly reported deferred share grant.